A new injectable weight loss treatment from the maker of Ozempic and Wegovy delivered 23% weight loss in trials, according to findings published in the New England journal and medicine. Dr. Roshini Raj, associate professor of medicine at NYU Langone Health, joins TODAY to compare the new injectable to others that are already available and shares an update on a trial of Eli Lilly’s oral weight loss pill that showed promising efficacy results.
When Could Eli Lilly’s Weight Loss Pill Hit the Market?
view original post